On January 17,2013, the U.S. FDA approved FluBlok, a faster-turnaround influenza vaccine grown in insect cells instead of eggs; it will be available in the 2013-14 season for people with egg allergies.
On January 17,2013, the U.S. FDA approved FluBlok, a faster-turnaround influenza vaccine which is the first grown in insect cells instead of eggs. It will be available in the 2013-14 season for people age 18-49, and avoids the problem with egg allergies.